Clinical Trial Update: Study to Evaluate the Effects of Oral Administration of Lixivaptan in Patients With Congestive Heart Failure [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial assessing oral lixivaptan in congestive heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Lixivaptan (lixivaptan)

Snippet

Sponsor: CardioKine Inc. | Conditions: Congestive Heart Failure | Phase 2 | Status: COMPLETED